Correlation between Peri-Implant Marginal Bone Loss Progression and Peri-Implant Sulcular Fluid Levels of Metalloproteinase-8

Abstract

Objectives: The aim of this retrospective study was to analyze peri-implant marginal bone loss levels/rates and peri-implant sulcular fluid levels/rates of metalloproteinase-8 in three timeframes (6 months post-surgery—restoration delivery (T0)—and 6 (T6) and 24 (T24)-months post-loading) and to evaluate if there is a correlation between peri-implant sulcular fluid levels of metalloproteinase-8 and peri-implant marginal bone loss progression. Materials and Methods: Two cohorts of patients undergoing implant surgery between January 2017 and January 2019 were selected in this retrospective study. A total of 39 patients received 39 implants with a laser-microtextured collar surface, and 41 subjects received 41 implants with a machined/smooth surface. For each patient, periapical radiographs and a software package were used to measure marginal bone loss rates. Implant fluid samples were analyzed by an enzyme-linked immunosorbent assay (ELISA) test. The modified plaque index, probing depth, and bleeding on probing were also recorded. Results: High marginal bone rates at T24 were strongly associated with elevated rates between T0 and T6. The levels of metalloproteinase-8 were significantly more elevated around implants with marginal bone loss, in relation to implants without marginal bone loss. Marginal bone loss (MBL) rates at 24 months were associated with initial bone loss rates and initial levels of metalloproteinase-8. Conclusions: Peri-implant marginal bone loss progression is statistically correlated to peri-implant sulcular fluid levels of metalloproteinase-8. Moreover, the initial high levels of marginal bone loss and metalloproteinase-8 can be considered as indicators of the subsequent progression of peri-implant MBL: implants with increased marginal bone loss rates and metalloproteinase-8 levels at 6 months after loading are likely to achieve additional marginal bone loss values.

Applications and Clinical Behavior of BioHPP in Prosthetic Dentistry: A Short Review

“…2015 [45] This new polymer material, introduced in prosthetic dentistry in 2013, may substitute metal or zirconium thanks to its extraordinary flexibility, great resistance, low weight, optimumpolishing features and low plaque affinity. 2021 [49] The results from this study suggest that PEEK can be a suitable material for use in provisional Fixed Dental Prosthesis during dental implant treatment. This consideration aimed to verify the convention of polyether ether ketone (PEEK) material as an attachment.…”

aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases

“…The recently published studies have well-documented novel aMMP-8 chairside tests to be valid, reliable, reproducible, sensitive, and specific [2,15,20,21,[26][27][28][29]. The results of these studies have established oral fluid aMMP-8 PoCT-test technology as a valid tool for addressing periodontal health and disease in both Caucasian adolescents and adults of Nigerian, Turkish, Indian, Chinese, Chilean, American, Greek, Malian, Italian, Finnish, and Swedish origin [15,19,21,22,25,[27][28][29][30][31][32][33][34][35][36].…”

“…MMP-8 cleaves not only type I-III collagens and various extracellular matrix (ECM) proteins but also non-matrix bioactive molecules such as serpins, bradykinin, angiotensin I, fibrinogen, insulin-receptor, and pro-and anti-inflammatory cyto-and chemokines involved to regulate immune and endocrinological processes [2,10,17]. MMP-8 is the most prevalent collagenolytic protease in the diseased periodontium and peri-implantium [2,[18][19][20]. Active MMP-8 (aMMP-8) is the major mediator of periodontitis and peri-implantitis tissue destruction [2,6,8,10,18].…”

Implant-Supported Prosthesis Is a Viable Treatment Alternative for American Society of Anesthesiology Physical Status 3 Individuals—A Retrospective Cohort Study

“…Implant survival may be altered by peri-implant molecules and proteins in sulcus fluids. Recent evidence demonstrates that peri-implant marginal bone loss progression is statistically correlated to sulcus fluid volume, IL-6, Il-1b concentrations, and peri-implant sulcular fluid levels of metalloproteinase-8 [ 7 , 8 ].…”